While anesthesia providers have only three modes to report to payers, one seems to cause a lot of confusion among professionals, according to a July 3 blog post from Rita Astani, president of ...

Please provide your email address to receive an email when new articles are posted on . Monitored anesthesia care increased total facility costs by about $176 vs. a wide-awake technique. Personnel and ...

Please provide your email address to receive an email when new articles are posted on . The incidence of altered mental status was 18% with monitored anesthesia care vs. 29% with general anesthesia.

On January 1, Blue Cross Blue Shield of Massachusetts implemented a policy that would have limited coverage of monitored anesthesia care for certain patients receiving colonoscopies and other ...

LUSEDRA (fospropofol disodium) 1,050mg/30mL injection by Eisai Eisai has made available Lusedra (fospropofol disodium injection), an intravenous water-soluble prodrug of the sedative-hypnotic agent ...

WOODCLIFF LAKE, N.J., Dec. 14 /PRNewswire/ -- Eisai Corporation of North America today announced that the U.S. Food and Drug Administration (FDA) has approved LUSEDRA(TM) (fospropofol disodium) ...

Anthem’s new policy states that this type of monitored anesthesia care is medically necessary only if the patient is under 18 years old, or is unable to cooperate or communicate because of dementia or ...

Anesthesia works by using medications (anesthetics) to temporarily block pain signals from traveling along your nerves to your brain, or by numbing the brain itself to cause unconsciousness. The ...

The FDA has approved Lusedra (fospropofol disodium, from Eisai), an intravenous sedative-hypnotic agent, for monitored anesthesia care (MAC) sedation in adults undergoing diagnostic or therapeutic ...